Joel Isaacson & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Joel Isaacson & Co's GILD Position: Q2 2026 in Review
Joel Isaacson & Co reduced its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, selling an estimated $4.35K and leaving 1,725 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #447.
Joel Isaacson & Co first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. The position peaked at $245K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Joel Isaacson & Co held 1,725 shares of Gilead Sciences worth $218K as of Q2 2026.
- Joel Isaacson & Co sold 33 Gilead Sciences shares in Q2 2026, an estimated $4.35K.
- Gilead Sciences made up 0.01% of Joel Isaacson & Co's portfolio in Q2 2026, its #447 holding.
- Joel Isaacson & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
- Joel Isaacson & Co's Gilead Sciences position peaked at $245K in Q1 2026.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.